tirzepatide adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide for the Maintenance of – Journal Club | Tirzepatide in

Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers Legal Alerts 2.12.26 Takeaways The bill would limit 503A pharmacies from compounding large volumes of drugs that are essentially copies of commercially available FDA-approved products

The clinical nuance is what Pfizer doesnt try to oversell: a non-placebo-adjusted number is not the same as a placebo-adjusted treatment effect

Thats because being in a calorie deficit forces your body to break down stored body fat (vs

With expert guidance and consistent support, youll begin to notice real changes

The shorter expiration date actually demonstrates the pharmacy's commitment to transparency and safety: they print the date they can confidently guarantee potency, rather than extending timelines without supporting data

Do not use Tirzepatide that has been frozen